Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Omeros Corp (OMER)  
$3.15 0.09 (2.94%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 61,650,000
Market Cap: 194.20(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.08 - $7.57
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 6.1
Insider 3/6 Months : 6.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Omeros is a commercial-stage biopharmaceutical company. Co. is focused on discovering, developing and commercializing small-molecule and protein therapeutics for larger-market as well as orphan indications targeting immunologic diseases. Co.'s drug candidate narsoplimab is the subject of a biologics license application pending before the U.S. Food and Drug Administration for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Co. has various late-stage clinical development programs in its pipeline, which are focused on: complement-mediated disorders, including immunoglobulin A nephropathy, atypical hemolytic uremic syndrome and COVID-19.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 25,000 25,000 25,000
Total Buy Value $0 $40,500 $40,500 $40,500
Total People Bought 0 2 2 2
Total Buy Transactions 0 2 2 2
Total Shares Sold 0 0 10,000 10,000
Total Sell Value $0 $0 $64,950 $64,950
Total People Sold 0 0 2 2
Total Sell Transactions 0 0 2 2
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 125
  Page 4 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cable Thomas J. Director   –       •      –    2016-12-14 4 AS $10.21 $30,642 D/D (3,000) 43,067     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-12-07 4 AS $10.48 $1,069,033 D/D (102,044) 1,884,985     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-12-07 4 OE $0.98 $100,003 D/D 102,044 1,987,029     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-12-06 4 AS $10.80 $1,101,808 D/D (102,040) 1,884,985     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-12-06 4 OE $0.98 $99,999 D/D 102,040 1,987,025     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-12-05 4 AS $10.71 $1,092,644 D/D (102,040) 1,884,985     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-12-05 4 OE $0.98 $99,999 D/D 102,040 1,987,025     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-12-02 4 OE $0.98 $277,539 D/D 283,203 1,884,985     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-12-02 4 AS $11.00 $1,122,593 D/D (102,040) 1,703,822     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-12-01 4 AS $11.56 $1,232,063 D/D (106,521) 1,703,822     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-12-01 4 OE $0.98 $104,391 D/D 106,521 1,810,343     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-11-30 4 AS $12.21 $1,191,478 D/D (97,559) 1,703,822     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2016-11-30 4 OE $0.98 $95,608 D/D 97,559 1,801,381     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-10-12 4 OE $6.05 $18,174 D/D 3,004 166,601     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-09-15 4 AS $10.91 $174,578 D/D (16,000) 163,597     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-09-15 4 OE $0.98 $15,680 D/D 16,000 179,597     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-08-15 4 AS $11.56 $183,826 D/D (15,900) 163,597     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-08-15 4 OE $0.98 $15,582 D/D 15,900 179,497     -
   Cable Thomas J. Director   –       •      –    2016-08-12 4 AS $11.52 $34,557 D/D (3,000) 46,067     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-07-15 4 AS $11.50 $182,804 D/D (15,900) 163,597     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-07-15 4 OE $0.98 $15,582 D/D 15,900 179,497     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-06-15 4 AS $11.42 $181,503 D/D (15,900) 163,597     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-06-15 4 OE $0.98 $15,582 D/D 15,900 179,497     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-05-16 4 AS $9.94 $158,057 D/D (15,900) 163,597     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2016-05-16 4 OE $0.98 $15,582 D/D 15,900 179,497     -
  125 Records found
  1  2  3  4  5   
  Page 4 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us